| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |